CAH

Cardinal Health, Inc. 10-Q Summary: Quarter Ended September 30, 1998

Business Context and Reporting Period

This Form 10-Q covers the three-month period ended September 30, 1998 (first quarter of fiscal 1999). Cardinal Health, Inc. operates primarily in the wholesale distribution of pharmaceuticals and healthcare services. The financial statements have been restated to reflect the pooling of interests mergers with MediQual Systems, Inc. (February 1998) and R.P. Scherer Corporation (August 1998). A three-for-two stock split was effected in October 1998, and all share data is retroactively adjusted.

Key Financial Metrics

Cash Flow: Net cash used in operating activities was $166.8 million, driven by increases in trade receivables ($46.9 million) and merchandise inventories ($95.6 million). Net cash provided by financing activities was $211.1 million, primarily due to $214.3 million in proceeds from long-term obligations.

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 25% year-over-year, with operating revenue up 27%. Distribution businesses grew 32%, while Service businesses grew 15%.
• Margin Compression: Gross margin percentage declined from 9.19% to 8.34%. This was attributed to a higher mix of lower-margin distribution business and competitive pressures leading to lower selling margins for high-volume customers.
• Merger-Related Costs: Costs surged to $34.4 million (net of tax: $27.8 million) compared to $2.2 million in the prior year. This included $12.5 million in restructuring and asset impairment costs related to the Scherer merger.
• Debt Levels: Long-term obligations increased significantly following the issuance of $150 million in 6.25% Notes due 2008 in July 1998.
• Effective Tax Rate: The effective tax rate rose to 43% from 36%, due to nondeductible items associated with recent business combinations.

Guidance, Outlook, and Risks

• Future Merger Costs: Management estimates an additional $32.3 million in merger-related costs will be incurred in future periods (primarily fiscal 1999 and 2000) to integrate completed mergers.
• Proposed Allegiance Merger: On October 9, 1998, Cardinal announced a definitive agreement to acquire Allegiance Corporation in a stock-for-stock transaction. The deal involves issuing approximately 73.5 million shares and assuming $838 million in long-term debt. Completion is expected in the first half of calendar 1999, subject to regulatory and shareholder approval.
• Terminated Bergen Merger: The proposed merger with Bergen Brunswig was terminated in August 1998 following an FTC injunction. Cardinal reimbursed Bergen $7 million but realized a $12.2 million tax benefit from previously incurred costs.
• Year 2000 Compliance: The company is in the remediation phase of its Year 2000 project, with total estimated costs of $24 million. Management does not anticipate a material adverse effect on operations but notes risks regarding third-party system failures.
• Legal Proceedings: Ongoing antitrust litigation regarding chargeback pricing systems is continuing, with trial proceedings active. The company believes the allegations are without merit.

Investor Verification Checklist

• Verify the impact of the pending Allegiance merger on future debt load and dilution (73.5M new shares, $838M debt assumption).
• Monitor the realization of the estimated $32.3 million in future merger integration costs.
• Assess the sustainability of gross margins given the shift toward lower-margin, high-volume distribution customers.
• Review the status of the antitrust litigation and potential exposure under the Judgment Sharing Agreement (capped at $1 million or 1% of judgment).
• Confirm the timeline and cost estimates for Year 2000 system remediation.